Preoperative medication use and postoperative delirium: a systematic review.
Gizat M Kassie, Tuan A Nguyen, Lisa M Kalisch Ellett...
https://pubmed.ncbi.nlm.nih.gov/29284416/Actively Recruiting
Led by Peking University First Hospital · Updated on 2025-07-30
1128
Participants Needed
6
Research Sites
52 weeks
Total Duration
Bladder cancer is a common urinary system cancer, with 70-80% being nonmuscle invasive types treated primarily by transurethral resection of bladder tumor TURBT. This study evaluates the effects of remimazolam, a new benzodiazepine with rapid onset and short action, on emergency delirium and cancer recurrence after bladder cancer surgery. Researchers are interested in comparing remimazolam to propofol anesthesia and understanding its impact on postoperative delirium and long-term cancer outcomes. Participants are randomly assigned to receive either remimazolam or propofol intravenously for anesthesia induction and maintenance during bladder tumor surgery. The anesthesia dose is adjusted to maintain a specific brain activity level Bispectral Index between 40 and 60. Pain relief and muscle relaxation are provided with other medications, and inhaled sevoflurane may be given if needed. Both groups receive similar supportive drugs to manage pain and muscle relaxation. During the study, patients are closely monitored for early emergence delirium within 2 hours post-surgery and for recurrence-free survival up to 3 years. Other outcomes include postoperative delirium, nausea, awareness during surgery, hospital stay length, complications, and survival rates. Assessments include clinical evaluations in the recovery unit and follow-up visits over several years to measure cancer recurrence and quality of life.
CONDITIONS
Impact of Remimazolam on Prognosis After Bladder Cancer Surgery
W
Wang Dong-Xin, MD, PhD
Z
Zhang Yu-Xiu, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Peking University First Hospital
Lead Sponsor
Beijing Tsinghua Chang Gung Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to the day of surgery
Participants receive general anesthesia with remimazolam or propofol during bladder cancer surgery (transurethral resection of bladder tumor).
1 surgical visit (in-person)
Duration - Up to 30 days after surgery
Participants are monitored for emergence delirium and other early outcomes such as postoperative delirium, nausea, awareness, and complications after surgery.
Approximately 1 to 5 visits during the first 30 days after surgery
Duration - Up to 3 years after surgery
Participants are followed to assess recurrence-free survival, overall survival, event-free survival, and quality of life after surgery.
Periodic visits up to 3 years (exact number varies)
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Gizat M Kassie, Tuan A Nguyen, Lisa M Kalisch Ellett...
https://pubmed.ncbi.nlm.nih.gov/29284416/E W Ely, S Gautam, R Margolin...
https://pubmed.ncbi.nlm.nih.gov/11797025/Basavana Gouda Goudra, Preet Mohinder Singh
https://pubmed.ncbi.nlm.nih.gov/25191193/Michele C Balas, Mary Beth Happ, Wei Yang...
https://pubmed.ncbi.nlm.nih.gov/19017895/John W Sear
https://pubmed.ncbi.nlm.nih.gov/29847365/Clemens R M Barends, Anthony R Absalom, Michel M R F Struys
https://pubmed.ncbi.nlm.nih.gov/30124543/R N Upton, A M Martinez, C Grant
https://pubmed.ncbi.nlm.nih.gov/19797247/Horst Bickel, Reiner Gradinger, Eberhard Kochs...
https://pubmed.ncbi.nlm.nih.gov/18577850/Marko Babjuk, Andreas Böhle, Maximilian Burger...
https://pubmed.ncbi.nlm.nih.gov/27324428/Chunyan Wang, Tanweer Datoo, Hailin Zhao...
https://pubmed.ncbi.nlm.nih.gov/30157038/Peking University First Hospital
Lead Sponsor
Beijing Tsinghua Chang Gung Hospital
Collaborating Sponsor